Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
RG-6315 by Genentech USA for Fibrosis: Likelihood of Approval
RG-6315 is under clinical development by Genentech USA and currently in Phase I for Fibrosis. According to GlobalData, Phase I...
RG-6315 by Genentech USA for Systemic Sclerosis (Scleroderma): Likelihood of Approval
RG-6315 is under clinical development by Genentech USA and currently in Phase I for Systemic Sclerosis (Scleroderma). According to GlobalData,...
RG-6315 by Genentech USA for Inflammation: Likelihood of Approval
RG-6315 is under clinical development by Genentech USA and currently in Phase I for Inflammation. According to GlobalData, Phase I...